About Matica Matica has an agreement with RoyalMax Biotechnology Canada Inc. for Matica to become a majority owner (70 per cent) of the late-stage applicant under the access to cannabis for medical purposes regulation (ACMPR). Matica and RoyalMax are diligently working to complete the build out of the 10,000-square-foot facility in Dorval, Que.